(Press-News.org) WASHINGTON — People with type-II diabetes who drank the fermented tea drink kombucha for four weeks had lower fasting blood glucose levels compared to when they consumed a similar-tasting placebo beverage, according to results from a clinical trial conducted by researchers at Georgetown University's School of Health, the University of Nebraska-Lincoln and MedStar Health. This finding, from a pilot 12-person feasibility trial, points to the potential for a dietary intervention that could help lower blood sugar levels in people with diabetes and also establishes the basis for a larger trial to confirm and expand upon these results.
This finding was reported in Frontiers in Nutrition on August 1, 2023.
Kombucha is a tea fermented with bacteria and yeasts and was consumed as early as 200 B.C. in China, but it did not become popular in the U.S. until the 1990s. Its popularity has been bolstered by anecdotal claims of improved immunity and energy and reductions in food cravings and inflammation, but proof of these benefits has been limited.
“Some laboratory and rodent studies of kombucha have shown promise and one small study in people without diabetes showed kombucha lowered blood sugar, but to our knowledge this is the first clinical trial examining effects of kombucha in people with diabetes,” says study author Dan Merenstein, M.D., professor of Human Sciences in Georgetown’s School of Health and professor of family medicine at Georgetown University School of Medicine. “A lot more research needs to be done but this is very promising.”
Merenstein continued, “A strength of our trial was that we didn't tell people what to eat because we used a crossover design that limited the effects of any variability in a person’s diet.”
The crossover design had one group of people drinking about eight ounces of kombucha or placebo beverage daily for four weeks and then after a two-month period to ‘wash out’ the biological effects of the beverages, the kombucha and placebo were swapped between groups with another four weeks of drinking the beverages. Neither group was told which drink they were receiving at the time.
Kombucha appeared to lower average fasting blood glucose levels after four weeks from 164 to 116 milligrams per deciliter while the difference after four weeks with the placebo was not statistically significant. Guidelines from the American Diabetes Association recommended blood sugar levels before meals should be between 70 to 130 milligrams per deciliter.
The researchers also looked at the makeup of fermenting micro-organisms in kombucha to determine which ingredients might be the most active. They found that the beverage was mainly comprised of lactic acid bacteria, acetic acid bacteria, and a form of yeast called Dekkera, with each microbe present in about equal measure; the finding was confirmed with RNA gene sequencing.
The kombucha used in this study was produced by Craft Kombucha, a commercial manufacturer in the Washington, DC, area. It has been re-branded as Brindle Boxer Kombucha.
“Different studies of different brands of kombucha by different manufacturers reveal slightly different microbial mixtures and abundances,” says Robert Hutkins, Ph.D., University of Nebraska-Lincoln and the study’s senior author. “However, the major bacteria and yeasts are highly reproducible and likely to be functionally similar between brands and batches, which was reassuring for our trial.”
“An estimated 96 million Americans have pre-diabetes -- and diabetes itself is the eighth leading cause of death in the U.S. as well as being a major risk factor for heart disease, stroke and kidney failure,” says Chagai Mendelson, M.D., lead author who was working in Merenstein’s lab at Georgetown while completing his residency at MedStar Health. “We were able to provide preliminary evidence that a common drink could have an effect on diabetes. We hope that a much larger trial, using the lessons we learned in this trial, could be undertaken to give a more definitive answer to the effectiveness of kombucha in reducing blood glucose levels, and hence prevent or help treat type-II diabetes.”
###
Additional study authors at Georgetown University are Sabrina Sparkes, a student in the School of Health, Varun Sharma and Sameer Desale. In addition to Hutkins, Chloe Christensen, Jennifer M. Auchtung, Car Reen Kok and Heather E. Hallen-Adams are at the University of Nebraska-Lincoln.
The authors wish to express their gratitude to Tanya Maynigo, founder of Craft Kombucha for providing the kombucha and placebo kombucha for this study. She teaches kombucha classes in Washington, DC, and this year is launching a new brand of her favorite drink called Brindle Boxer Kombucha.
The study received no external funding.
Hutkins is a co-founder of Synbiotic Health. Auchtung has a financial interest in Synbiotic Health. Merenstein is president of the International Scientific Association for Probiotics and Prebiotics board, a non-paid position. All other authors have no competing interests to declare. All kombucha and placebo drinks were donated by Craft Kombucha. Craft Kombucha did not have any access to data reported in this study. No author has any financial ties with Craft Kombucha.
About Georgetown University Medical Center
As a top academic health and science center, Georgetown University Medical Center provides, in a synergistic fashion, excellence in education — training physicians, nurses, health administrators and other health professionals, as well as biomedical scientists — and cutting-edge interdisciplinary research collaboration, enhancing our basic science and translational biomedical research capacity in order to improve human health. Patient care, clinical research and education is conducted with our academic health system partner, MedStar Health. GUMC’s mission is carried out with a strong emphasis on social justice and a dedication to the Catholic, Jesuit principle of cura personalis -- or “care of the whole person.” GUMC comprises the School of Medicine, the School of Nursing, School of Health, Biomedical Graduate Education, and Georgetown Lombardi Comprehensive Cancer Center. Designated by the Carnegie Foundation as a doctoral university with "very high research activity,” Georgetown is home to a Clinical and Translational Science Award from the National Institutes of Health, and a Comprehensive Cancer Center designation from the National Cancer Institute. Connect with GUMC on Facebook (Facebook.com/GUMCUpdate) and on Twitter (@gumedcenter).
END
Researchers at the RIKEN Center for Sustainable Research Science (CSRS) and the University of Toronto have discovered a new way to attack fungal infections. The key is to block fungi from being able to make fatty acids, the major component of fats. Resistance to anti-fungal drugs is increasing and this new approach will be particularly useful because it works in a new way and affects a broad range of fungal species. The study was published in the scientific journal Cell Chemical Biology.
Most of us are familiar with athlete’s ...
Only 28.5% of Thai women are diagnosed at stage I of cervical cancer when survival rates are highest, according to a study published by the Mahidol University. To further motivate action to combat cervical cancer, BGI Genomics released its State of Cervical Cancer Awareness Report in Thailand. This report assesses the level of knowledge, attitudes, and practices related to cervical cancer screening and HPV vaccination to highlight the associated barriers and opportunities. 1,878 female respondents from six countries and ...
Researchers have revealed the unique ‘cheating’ strategy a New Zealand insect has developed to avoid being eaten – mimicking a highly toxic species.
In nature, poisonous species typically advertise their toxicity, often by producing high contrast colours such as black, white and yellow, like wasps and bees.
Along similar lines, New Zealand’s cyanide-producing stonefly, Austroperla cyrene, produces strong ‘warning’ colours of black, white and yellow, to highlight its threat to potential predators.
In a new study published in Molecular Ecology, University of Otago Department of Zoology researchers reveal that an ...
It’s an elegant solution: Remove the habitat of a parasite-carrying aquatic snail and reduce the level of infection in the local community; all while generating more feed and compost for local farmers.
A collaboration of scientists from the United States and Senegal focused on doing just that by removing overgrown aquatic vegetation from areas upstream of the Diama Dam in northeastern Senegal. In doing so, they generated positive impacts to the local communities’ health and economies.
“It is rare and gratifying when we can find a potential win-win solution to both human health ...
**Embargo: 23.30 [UK time] / 6.30pm [ET] Monday, July 31, 2023**
Peer-reviewed
The Lancet: New study reveals global anemia cases remain ...
Oat is among the top ten cereal crop species in terms of global production. It can adapt to different climates, and farmers can grow it successfully even in harsh environments where other crops such as rice and corn fail. However, not all oat plants are the same. Based on their grains, two major oak varieties can easily be distinguished: hulled, grains that are covered in a non-edible husk, and naked, grains that have a soft outer casing that easily separates from the edible grain during threshing. To gain information on the origins of these different varieties, researchers in China have sequenced the ...
With a Fulton County indictment of former President Donald Trump possible at any time, law enforcement in Atlanta is bracing for potential violence, with orange barricades restricting access to the entrance of the county courthouse.
With the anticipation of each new indictment has come threats of violence, decrease in trust in American justice and calls for retribution against the government. Just how concerned should Americans be that we may face another January 6th-type incident?
New data from the Polarization ...
Sperm play a critical role in the creation of new life, delivering essentially half of the genetic material required.
The success of this process relies on the generation of a developmentally competent sperm cell, which is often determined by shape. Indeed, during in vitro fertilization, the “best-looking” sperm is selected to fertilize an egg.
However, how this optimal shape translates to proper sperm function is difficult to assess because of many confounding factors.
Researchers at the University of Michigan are now delving into the molecular-level details of sperm formation, with a particular focus on how abnormalities in ...
Technological advancements like autonomous driving and computer vision are driving a surge in demand for computational power. Optical computing, with its high throughput, energy efficiency, and low latency, has garnered considerable attention from academia and industry. However, current optical computing chips face limitations in power consumption and size, which hinders the scalability of optical computing networks.
Thanks to the rise of nonvolatile integrated photonics, optical computing devices can achieve in-memory computing while operating with zero static power consumption. Phase-change materials (PCMs) have emerged as promising candidates for achieving photonic memory and nonvolatile ...
New research reveals a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis, or ALS, a fatal neurodegenerative disease.
The study, led by scientists at Oregon Health & Science University, published today in the Proceedings of the National Academy of Sciences.
The study, involving a mouse model and confirmed in the tissue of human brains affected by ALS and donated after death, revealed for the first time that modulating immune cells can slow the progression of the disease. Previous research suggested a role for immune cells in ALS, but researchers this time used a high-throughput ...
